TY  - JOUR
AU  - Díaz-Perdigones, Cristina Ma
AU  - Muñoz-Garach, Araceli
AU  - Álvarez-Bermúdez, María Dolores
AU  - Moreno-Indias, Isabel
AU  - Tinahones, Francisco J
PY  - 2021
DO  - 10.1016/j.biopha.2021.112448
UR  - http://hdl.handle.net/10668/22037
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AB  - Metformin modifies the gut microbiome in type 2 diabetes and gastrointestinal tolerance to metformin could be mediated by the gut microbiome. We enrolled 35 patients with type 2 diabetes not receiving treatment with metformin due to suspected...
LA  - en
KW  - Adverse drug reactions
KW  - Gastrointestinal
KW  - Gut microbiome
KW  - Metformin
KW  - Aged
KW  - Diabetes Mellitus, Type 2
KW  - Female
KW  - Follow-Up Studies
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Prospective Studies
TI  - Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
TY  - research article
VL  - 145
ER  -